Current anticoagulant therapy—unmet clinical needs
- 1 July 2003
- journal article
- review article
- Published by Elsevier in Thrombosis Research
- Vol. 109, S1-S8
- https://doi.org/10.1016/s0049-3848(03)00250-0
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Blood coagulationThe Lancet, 2000
- Antithrombotic Effects and Bleeding Time of Thrombin Inhibitors and Warfarin in the RatThrombosis Research, 1999
- Oral AnticoagulantsChest, 1998
- The Protein C Pathway: New InsightsThrombosis and Haemostasis, 1997
- Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and SafetyChest, 1995
- Tissue Factor Pathway InhibitorThrombosis and Haemostasis, 1995
- Molecular and Cellular Biology of Blood CoagulationNew England Journal of Medicine, 1992
- Oral Anticoagulant DrugsNew England Journal of Medicine, 1991
- HeparinNew England Journal of Medicine, 1991
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990